Loading…

Fibrinogen-to-Neutrophil Ratio as a New Predictor of Central Lymph Node Metastasis in Patients with Papillary Thyroid Cancer and Type 2 Diabetes Mellitus

Many patients have a higher risk of thyroid cancer if they have both papillary thyroid carcinoma (PTC) and Type 2 diabetes mellitus (T2DM). Meanwhile, the primary reason for local PTC recurrence is cervical lymph node metastasis. Therefore, the prognosis of patients affects how cervical lymph nodes...

Full description

Saved in:
Bibliographic Details
Published in:Cancer management and research 2022-01, Vol.14, p.3493-3505
Main Authors: Zheng, Danni, Yang, Jiawen, Qian, Jiali, Jin, Lingli, Huang, Guanli
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c588t-7d4e40f7d1e4d5ed079e2b087ae480ece729d720f7025de7df910d5a26a6a3743
cites cdi_FETCH-LOGICAL-c588t-7d4e40f7d1e4d5ed079e2b087ae480ece729d720f7025de7df910d5a26a6a3743
container_end_page 3505
container_issue
container_start_page 3493
container_title Cancer management and research
container_volume 14
creator Zheng, Danni
Yang, Jiawen
Qian, Jiali
Jin, Lingli
Huang, Guanli
description Many patients have a higher risk of thyroid cancer if they have both papillary thyroid carcinoma (PTC) and Type 2 diabetes mellitus (T2DM). Meanwhile, the primary reason for local PTC recurrence is cervical lymph node metastasis. Therefore, the prognosis of patients affects how cervical lymph nodes are managed during surgery. Due to surgical complications such as laryngeal nerve palsy and hypocalcemia, it is still debatable whether to prevent central lymph node dissection (CLND). Predicting central lymph node metastasis (CLNM) is crucial to direct CLND. It is unclear how important the fibrinogen-to-neutrophil ratio (FNR) is in thyroid cancer, so we looked into how it might help patients with PTC and T2DM predict CLNM. Wenzhou Medical University's First Affiliated Hospital provided us with 413 patients with PTC and T2DM, randomly divided into a training set (N = 292) and a validation set (N = 121). Univariate and multivariate logistic regression analyses were used to identify independent risk factors. After constructing a nomogram, the validity of the model was evaluated. The maximum tumor diameter, high-density lipoprotein, thyroxine, triglyceride, lymphocyte, and FNR were all identified as independent risk factors by multivariate logistic regression analysis. The C index of the training set was 0.775, and the validation set was 0.654. In patients with PTC and T2DM, preoperative FNR was an independent risk factor for CLNM.
doi_str_mv 10.2147/CMAR.S366270
format article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_60f7aeb66c884cc0b7472a0cc3596d59</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A732979964</galeid><doaj_id>oai_doaj_org_article_60f7aeb66c884cc0b7472a0cc3596d59</doaj_id><sourcerecordid>A732979964</sourcerecordid><originalsourceid>FETCH-LOGICAL-c588t-7d4e40f7d1e4d5ed079e2b087ae480ece729d720f7025de7df910d5a26a6a3743</originalsourceid><addsrcrecordid>eNptks9v0zAUgCMEYmNw44wsceFAiu0kdnxBqgqDSV2ZRjlbjv3SukrjYDtM_VP4b3FpGStCtuRf3_tsP70se0nwhJKSv5tdT28nXwvGKMePsnNCuMhJQenjB_Oz7FkIG4yZIEX5NDsrWMULwvh59vPSNt72bgV9Hl2-gDF6N6xth25VtA6pgBRawB268WCsjs4j16IZ9NGrDs1322GNFs4AuoaoQuo2INujmxScmIDubFyn1WC7TvkdWq533lmDZqrX4JHqDVruBkAUfbCqgQghibrOxjE8z560qgvw4jheZN8uPy5nn_P5l09Xs-k811Vdx5ybEkrcckOgNBUYzAXQBtdcQVlj0MCpMJwmAtPKADetINhUijLFVMHL4iK7OniNUxs5eLtND5VOWfl7w_mVVD5a3YFkyaKgYUzXdak1bnjJqcJaF5VgphLJ9f7gGsZmC0Yf0nQiPT3p7Vqu3A8peC04Jknw5ijw7vsIIcqtDTplRPXgxiApr-qK10SwhL7-B9240fcpVYlijFSC0_IvtVLpA7ZvXbpX76VyygsquBBsT03-Q6VmYGu166G1af8k4O0hQHsXgof2_o8Ey31Zyn1ZymNZJvzVw7zcw3_qsPgF4Z7dvg</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2766159724</pqid></control><display><type>article</type><title>Fibrinogen-to-Neutrophil Ratio as a New Predictor of Central Lymph Node Metastasis in Patients with Papillary Thyroid Cancer and Type 2 Diabetes Mellitus</title><source>Publicly Available Content Database</source><source>Taylor &amp; Francis Open Access Journals</source><source>PubMed Central</source><creator>Zheng, Danni ; Yang, Jiawen ; Qian, Jiali ; Jin, Lingli ; Huang, Guanli</creator><creatorcontrib>Zheng, Danni ; Yang, Jiawen ; Qian, Jiali ; Jin, Lingli ; Huang, Guanli</creatorcontrib><description>Many patients have a higher risk of thyroid cancer if they have both papillary thyroid carcinoma (PTC) and Type 2 diabetes mellitus (T2DM). Meanwhile, the primary reason for local PTC recurrence is cervical lymph node metastasis. Therefore, the prognosis of patients affects how cervical lymph nodes are managed during surgery. Due to surgical complications such as laryngeal nerve palsy and hypocalcemia, it is still debatable whether to prevent central lymph node dissection (CLND). Predicting central lymph node metastasis (CLNM) is crucial to direct CLND. It is unclear how important the fibrinogen-to-neutrophil ratio (FNR) is in thyroid cancer, so we looked into how it might help patients with PTC and T2DM predict CLNM. Wenzhou Medical University's First Affiliated Hospital provided us with 413 patients with PTC and T2DM, randomly divided into a training set (N = 292) and a validation set (N = 121). Univariate and multivariate logistic regression analyses were used to identify independent risk factors. After constructing a nomogram, the validity of the model was evaluated. The maximum tumor diameter, high-density lipoprotein, thyroxine, triglyceride, lymphocyte, and FNR were all identified as independent risk factors by multivariate logistic regression analysis. The C index of the training set was 0.775, and the validation set was 0.654. In patients with PTC and T2DM, preoperative FNR was an independent risk factor for CLNM.</description><identifier>ISSN: 1179-1322</identifier><identifier>EISSN: 1179-1322</identifier><identifier>DOI: 10.2147/CMAR.S366270</identifier><identifier>PMID: 36573167</identifier><language>eng</language><publisher>New Zealand: Dove Medical Press Limited</publisher><subject>Calibration ; Cancer patients ; Care and treatment ; clnm ; Complications and side effects ; Datasets ; Diabetes ; Fibrin ; Fibrinogen ; fnr ; Lymphatic system ; Lymphocytes ; Medical colleges ; Medical prognosis ; Medical research ; Medicine, Experimental ; Metastasis ; Multivariate analysis ; Neutrophils ; nomogram ; Nomograms ; Original Research ; Patients ; Performance evaluation ; predictor ; Prognosis ; ptc ; Regression analysis ; Risk factors ; Surgery ; Surgical outcomes ; Thyroid cancer ; Thyroxine ; Type 2 diabetes</subject><ispartof>Cancer management and research, 2022-01, Vol.14, p.3493-3505</ispartof><rights>2022 Zheng et al.</rights><rights>COPYRIGHT 2022 Dove Medical Press Limited</rights><rights>2022. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2022 Zheng et al. 2022 Zheng et al.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c588t-7d4e40f7d1e4d5ed079e2b087ae480ece729d720f7025de7df910d5a26a6a3743</citedby><cites>FETCH-LOGICAL-c588t-7d4e40f7d1e4d5ed079e2b087ae480ece729d720f7025de7df910d5a26a6a3743</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2766159724/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2766159724?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25751,27922,27923,37010,37011,44588,53789,53791,74896</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36573167$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zheng, Danni</creatorcontrib><creatorcontrib>Yang, Jiawen</creatorcontrib><creatorcontrib>Qian, Jiali</creatorcontrib><creatorcontrib>Jin, Lingli</creatorcontrib><creatorcontrib>Huang, Guanli</creatorcontrib><title>Fibrinogen-to-Neutrophil Ratio as a New Predictor of Central Lymph Node Metastasis in Patients with Papillary Thyroid Cancer and Type 2 Diabetes Mellitus</title><title>Cancer management and research</title><addtitle>Cancer Manag Res</addtitle><description>Many patients have a higher risk of thyroid cancer if they have both papillary thyroid carcinoma (PTC) and Type 2 diabetes mellitus (T2DM). Meanwhile, the primary reason for local PTC recurrence is cervical lymph node metastasis. Therefore, the prognosis of patients affects how cervical lymph nodes are managed during surgery. Due to surgical complications such as laryngeal nerve palsy and hypocalcemia, it is still debatable whether to prevent central lymph node dissection (CLND). Predicting central lymph node metastasis (CLNM) is crucial to direct CLND. It is unclear how important the fibrinogen-to-neutrophil ratio (FNR) is in thyroid cancer, so we looked into how it might help patients with PTC and T2DM predict CLNM. Wenzhou Medical University's First Affiliated Hospital provided us with 413 patients with PTC and T2DM, randomly divided into a training set (N = 292) and a validation set (N = 121). Univariate and multivariate logistic regression analyses were used to identify independent risk factors. After constructing a nomogram, the validity of the model was evaluated. The maximum tumor diameter, high-density lipoprotein, thyroxine, triglyceride, lymphocyte, and FNR were all identified as independent risk factors by multivariate logistic regression analysis. The C index of the training set was 0.775, and the validation set was 0.654. In patients with PTC and T2DM, preoperative FNR was an independent risk factor for CLNM.</description><subject>Calibration</subject><subject>Cancer patients</subject><subject>Care and treatment</subject><subject>clnm</subject><subject>Complications and side effects</subject><subject>Datasets</subject><subject>Diabetes</subject><subject>Fibrin</subject><subject>Fibrinogen</subject><subject>fnr</subject><subject>Lymphatic system</subject><subject>Lymphocytes</subject><subject>Medical colleges</subject><subject>Medical prognosis</subject><subject>Medical research</subject><subject>Medicine, Experimental</subject><subject>Metastasis</subject><subject>Multivariate analysis</subject><subject>Neutrophils</subject><subject>nomogram</subject><subject>Nomograms</subject><subject>Original Research</subject><subject>Patients</subject><subject>Performance evaluation</subject><subject>predictor</subject><subject>Prognosis</subject><subject>ptc</subject><subject>Regression analysis</subject><subject>Risk factors</subject><subject>Surgery</subject><subject>Surgical outcomes</subject><subject>Thyroid cancer</subject><subject>Thyroxine</subject><subject>Type 2 diabetes</subject><issn>1179-1322</issn><issn>1179-1322</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNptks9v0zAUgCMEYmNw44wsceFAiu0kdnxBqgqDSV2ZRjlbjv3SukrjYDtM_VP4b3FpGStCtuRf3_tsP70se0nwhJKSv5tdT28nXwvGKMePsnNCuMhJQenjB_Oz7FkIG4yZIEX5NDsrWMULwvh59vPSNt72bgV9Hl2-gDF6N6xth25VtA6pgBRawB268WCsjs4j16IZ9NGrDs1322GNFs4AuoaoQuo2INujmxScmIDubFyn1WC7TvkdWq533lmDZqrX4JHqDVruBkAUfbCqgQghibrOxjE8z560qgvw4jheZN8uPy5nn_P5l09Xs-k811Vdx5ybEkrcckOgNBUYzAXQBtdcQVlj0MCpMJwmAtPKADetINhUijLFVMHL4iK7OniNUxs5eLtND5VOWfl7w_mVVD5a3YFkyaKgYUzXdak1bnjJqcJaF5VgphLJ9f7gGsZmC0Yf0nQiPT3p7Vqu3A8peC04Jknw5ijw7vsIIcqtDTplRPXgxiApr-qK10SwhL7-B9240fcpVYlijFSC0_IvtVLpA7ZvXbpX76VyygsquBBsT03-Q6VmYGu166G1af8k4O0hQHsXgof2_o8Ey31Zyn1ZymNZJvzVw7zcw3_qsPgF4Z7dvg</recordid><startdate>20220101</startdate><enddate>20220101</enddate><creator>Zheng, Danni</creator><creator>Yang, Jiawen</creator><creator>Qian, Jiali</creator><creator>Jin, Lingli</creator><creator>Huang, Guanli</creator><general>Dove Medical Press Limited</general><general>Taylor &amp; Francis Ltd</general><general>Dove</general><general>Dove Medical Press</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20220101</creationdate><title>Fibrinogen-to-Neutrophil Ratio as a New Predictor of Central Lymph Node Metastasis in Patients with Papillary Thyroid Cancer and Type 2 Diabetes Mellitus</title><author>Zheng, Danni ; Yang, Jiawen ; Qian, Jiali ; Jin, Lingli ; Huang, Guanli</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c588t-7d4e40f7d1e4d5ed079e2b087ae480ece729d720f7025de7df910d5a26a6a3743</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Calibration</topic><topic>Cancer patients</topic><topic>Care and treatment</topic><topic>clnm</topic><topic>Complications and side effects</topic><topic>Datasets</topic><topic>Diabetes</topic><topic>Fibrin</topic><topic>Fibrinogen</topic><topic>fnr</topic><topic>Lymphatic system</topic><topic>Lymphocytes</topic><topic>Medical colleges</topic><topic>Medical prognosis</topic><topic>Medical research</topic><topic>Medicine, Experimental</topic><topic>Metastasis</topic><topic>Multivariate analysis</topic><topic>Neutrophils</topic><topic>nomogram</topic><topic>Nomograms</topic><topic>Original Research</topic><topic>Patients</topic><topic>Performance evaluation</topic><topic>predictor</topic><topic>Prognosis</topic><topic>ptc</topic><topic>Regression analysis</topic><topic>Risk factors</topic><topic>Surgery</topic><topic>Surgical outcomes</topic><topic>Thyroid cancer</topic><topic>Thyroxine</topic><topic>Type 2 diabetes</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zheng, Danni</creatorcontrib><creatorcontrib>Yang, Jiawen</creatorcontrib><creatorcontrib>Qian, Jiali</creatorcontrib><creatorcontrib>Jin, Lingli</creatorcontrib><creatorcontrib>Huang, Guanli</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Cancer management and research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zheng, Danni</au><au>Yang, Jiawen</au><au>Qian, Jiali</au><au>Jin, Lingli</au><au>Huang, Guanli</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Fibrinogen-to-Neutrophil Ratio as a New Predictor of Central Lymph Node Metastasis in Patients with Papillary Thyroid Cancer and Type 2 Diabetes Mellitus</atitle><jtitle>Cancer management and research</jtitle><addtitle>Cancer Manag Res</addtitle><date>2022-01-01</date><risdate>2022</risdate><volume>14</volume><spage>3493</spage><epage>3505</epage><pages>3493-3505</pages><issn>1179-1322</issn><eissn>1179-1322</eissn><abstract>Many patients have a higher risk of thyroid cancer if they have both papillary thyroid carcinoma (PTC) and Type 2 diabetes mellitus (T2DM). Meanwhile, the primary reason for local PTC recurrence is cervical lymph node metastasis. Therefore, the prognosis of patients affects how cervical lymph nodes are managed during surgery. Due to surgical complications such as laryngeal nerve palsy and hypocalcemia, it is still debatable whether to prevent central lymph node dissection (CLND). Predicting central lymph node metastasis (CLNM) is crucial to direct CLND. It is unclear how important the fibrinogen-to-neutrophil ratio (FNR) is in thyroid cancer, so we looked into how it might help patients with PTC and T2DM predict CLNM. Wenzhou Medical University's First Affiliated Hospital provided us with 413 patients with PTC and T2DM, randomly divided into a training set (N = 292) and a validation set (N = 121). Univariate and multivariate logistic regression analyses were used to identify independent risk factors. After constructing a nomogram, the validity of the model was evaluated. The maximum tumor diameter, high-density lipoprotein, thyroxine, triglyceride, lymphocyte, and FNR were all identified as independent risk factors by multivariate logistic regression analysis. The C index of the training set was 0.775, and the validation set was 0.654. In patients with PTC and T2DM, preoperative FNR was an independent risk factor for CLNM.</abstract><cop>New Zealand</cop><pub>Dove Medical Press Limited</pub><pmid>36573167</pmid><doi>10.2147/CMAR.S366270</doi><tpages>13</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1179-1322
ispartof Cancer management and research, 2022-01, Vol.14, p.3493-3505
issn 1179-1322
1179-1322
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_60f7aeb66c884cc0b7472a0cc3596d59
source Publicly Available Content Database; Taylor & Francis Open Access Journals; PubMed Central
subjects Calibration
Cancer patients
Care and treatment
clnm
Complications and side effects
Datasets
Diabetes
Fibrin
Fibrinogen
fnr
Lymphatic system
Lymphocytes
Medical colleges
Medical prognosis
Medical research
Medicine, Experimental
Metastasis
Multivariate analysis
Neutrophils
nomogram
Nomograms
Original Research
Patients
Performance evaluation
predictor
Prognosis
ptc
Regression analysis
Risk factors
Surgery
Surgical outcomes
Thyroid cancer
Thyroxine
Type 2 diabetes
title Fibrinogen-to-Neutrophil Ratio as a New Predictor of Central Lymph Node Metastasis in Patients with Papillary Thyroid Cancer and Type 2 Diabetes Mellitus
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T23%3A18%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Fibrinogen-to-Neutrophil%20Ratio%20as%20a%20New%20Predictor%20of%20Central%20Lymph%20Node%20Metastasis%20in%20Patients%20with%20Papillary%20Thyroid%20Cancer%20and%20Type%202%20Diabetes%20Mellitus&rft.jtitle=Cancer%20management%20and%20research&rft.au=Zheng,%20Danni&rft.date=2022-01-01&rft.volume=14&rft.spage=3493&rft.epage=3505&rft.pages=3493-3505&rft.issn=1179-1322&rft.eissn=1179-1322&rft_id=info:doi/10.2147/CMAR.S366270&rft_dat=%3Cgale_doaj_%3EA732979964%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c588t-7d4e40f7d1e4d5ed079e2b087ae480ece729d720f7025de7df910d5a26a6a3743%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2766159724&rft_id=info:pmid/36573167&rft_galeid=A732979964&rfr_iscdi=true